RenovoRx, Inc. (RNXT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.02M | -1.8% |
| 2024 | $7.15M | +509.9% |
| 2023 | $1.17M | -73.3% |
| 2022 | $4.39M | -71.1% |
| 2021 | $15.19M | +746.4% |
| 2020 | $1.79M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.02M | -1.8% |
| 2024 | $7.15M | +509.9% |
| 2023 | $1.17M | -73.3% |
| 2022 | $4.39M | -71.1% |
| 2021 | $15.19M | +746.4% |
| 2020 | $1.79M | — |